MITOCARE: TRO40303 Hopes Dashed For Preventing Reperfusion Injury After Heart Attack
Tuesday, September 2, 2014 - 12:01
in Health & Medicine
Reperfusion injury prevention isn't possible just yet. The administration of an experimental agent known as TRO40303 to patients who have had a heart attack, with the hope of preventing tissue damage when impaired blood flow is corrected (reperfusion), was disappointingly ineffective, according to results of a European study of patients with acute ST-elevation myocardial infarction (STEMI) presented today at ESC Congress 2014 and published in the European Heart Journal. read more